Navigation Links
Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
Date:9/20/2010

ST. LOUIS, Sept. 20 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) today announced that the U.S. Patent and Trademark Office granted the Company its 100th patent, a major intellectual property milestone. The 100th patent, U.S. patent No. 7,772,950, covers the "Method and Apparatus for Dynamic Magnetic Field Control Using Multiple Magnets."  The 100th patent reflects Stereotaxis' ongoing commitment to innovate and protect its leading position in robotic solutions for interventional medicine.  

"Our 100th patent represents a significant milestone in Stereotaxis' drive to protect shareholder value and deliver innovative technologies that improve treatment options for patients with cardiovascular disease," said Michael P. Kaminski, President and Chief Executive Officer. "Our strong intellectual property position enables the delivery of measurable clinical benefits across the broadest range of cardiovascular, neurovascular, peripheral vascular and other interventional applications, including treatment of ventricular tachycardia with high levels of acute success."

For more than 15 years, Stereotaxis has built a robust intellectual property portfolio, which includes these 100 issued patents and over 100 additional patent applications in process for approval.  Stereotaxis' extensive U.S. patent portfolio is supplemented by more than 30 non-U.S. patents and patent applications.  The Company anticipates doubling the number of non-U.S. patents in the next few months as patents issue on its Niobe® Magnetic Navigation System. The patents issued to date include remote/robotic assisted cardiology procedures, diagnostic integration, therapeutic devices, software automation, and information technology for patient/case management.

For the past two years, Stereotaxis ranked in the top 10 of IEEE Spectrum's Patent Power Scorecard, a rating of the world's
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference
2. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
3. Stereotaxis Announces Second Quarter 2010 Earnings Release Date and Conference Call
4. New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects
5. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
6. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
7. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
8. Stereotaxis Installs First System in Taiwan
9. Stereotaxis System Procedure Featured on NBCs The TODAY Show
10. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
11. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  MEI Pharma, ... the clinical development of novel therapies for cancer, announced today ... Executive Officer, will present at the inaugural Cantor Fitzgerald Healthcare ... time from Le Parker Meridien in ... can be accessed at www.meipharma.com . A replay will ...
(Date:7/1/2015)... July 1, 2015 Lupin ... Total Number of MPP Sub-licensees to Fourteen Companies ... Pool (MPP) announced the rapid expansion of its network of ... 50 projects to develop MPP-licensed antiretrovirals (ARVs). New companies Lupin ... a promising new HIV medicine the MPP licensed from ViiV ...
(Date:7/1/2015)... 2015  AVACEN, Inc. announced today the issue by the ... medical technology platform supporting its unique Dry Heat Therapy AVACEN ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... 9,066,781 - Methods And Apparatus For Therapeutic Application of Thermal ... methods of use, referred to by the company as the ...
Breaking Medicine Technology:MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3AVACEN Medical Patent Issued 2
... OAKS, Calif., April 13, 2011 Amgen (NASDAQ: ... first quarter financial results on Wednesday, April 20, 2011 after ... be followed by a conference call with the investment community ... Amgen will be Kevin Sharer, chairman and chief executive officer, ...
... 13, 2011 Perrigo (Nasdaq: PRGO;TASE) today announced that ... TEVA ), has received final OTC approval to sell ... tablets; the generic equivalents of Sanofi-Aventis, Allegra 60 mg ... for these products, and Teva and Sanofi-Aventis have settled ...
Cached Medicine Technology:Amgen Announces Webcast of 2011 First Quarter Financial Results 2Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets 2Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets 3
(Date:7/1/2015)... ... July 01, 2015 , ... Convoy of Hope will ... the Twin Cities on Saturday, August 1, at Spring Lake Park High School. , ... more than $1 million worth of goods and services including free food, health services, ...
(Date:7/1/2015)... ... 2015 , ... Scoliosis is a disorder in which the normally straight vertical line of the ... 3 percent of the population, or an estimated 6 to 9 million people. While it ... ages of 10 and 15. Most types of scoliosis are more common in girls than ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... compensation law has just published a top ten list they hope will guide ... Click here to read it now. , More than 450 ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the only ... a national chief nursing officer recruitment for Capital Health in ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... Research ... Examination Kit (Peek) smartphone app to test eyesight was just as accurate as those ... School of Hygiene and Tropical Medicine is responsible for the development of the test, ...
Breaking Medicine News(10 mins):Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3
... with golf tournament on August 4th, 2008 , ... Woburn, MA (PRWEB) ... that it will partner with Ovations for the Cure to promote awareness ... with the Driving for a Cure Golf Tournament on August 4th, 2008 ...
... A Women,s Cancer Initiative in Partnership with the Entertainment Industry ... Foundation,s Women,s Cancer Research Fund, ... Industry Foundation (EIF) announced today that Academy,Award(R) winning actress Gwyneth ... Fifth Avenue,s 2008 KEY TO THE CURE,campaign. KEY TO THE ...
... Senior Living,Inc. (NYSE: SRZ ) today updated ... webcast to discuss the Company,s 2007 financial results,and ... call will now be held on Friday, August ... issue its 2007 financial results and second-quarter 2008,preliminary ...
... action is largely perceived as a legitimate means ... shown industrial action can adversely affect those involved. ... at Griffith University, has examined the psychological impact ... while on strike from 2004-2006. , She ...
... women treated for breast cancer did not know that their ... same whether they undergo mastectomy or breast conserving surgery. Minority ... important factor of their treatment decision, according to a study ... women were also less likely to know about relative survival ...
... Preliminary results from Milliman,s,2008 Group Health Insurance Survey ... official rate of inflation but are lower than,premium ... renewal,increases of 8.5% for Health Maintenance Organizations (HMOs) ... trend toward lower,increases since peaking at 16.1% in ...
Cached Medicine News:Health News:SBLI and Ovations for the Cure Team up to Raise Cancer Awareness 2Health News:Gwyneth Paltrow Announced as EIF Ambassador to Saks Fifth Avenue's 2008 KEY TO THE CURE Campaign 2Health News:Gwyneth Paltrow Announced as EIF Ambassador to Saks Fifth Avenue's 2008 KEY TO THE CURE Campaign 3Health News:Gwyneth Paltrow Announced as EIF Ambassador to Saks Fifth Avenue's 2008 KEY TO THE CURE Campaign 4Health News:Sunrise Updates Date and Time of Conference Call to Discuss 2007 Financial Results and Second-Quarter 2008 Preliminary Selected Financial and Operating Data 2Health News:Psychological downside to strike action 2Health News:Minorities less likely to know about breast cancer treatment options 2Health News:Minorities less likely to know about breast cancer treatment options 3Health News:Milliman Survey Indicates Lower Health Insurance Rate Increases 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: